{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:13:42Z","timestamp":1778912022545,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007642","name":"Universit\u00e0 degli Studi di Roma Tor Vergata","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007642","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thymic epithelial tumors presented a variable 5-year survival rate, histological subtype dependent. Efforts have been made to identify new prognostic markers. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and Systemic Inflammatory Index (SII) proved effective in predicting survival in other solid tumors. We evaluated the prognostic significance of NLR, PLR, and SII on disease-free, overall, and tumor-related survivals in patients undergoing surgery with radical intent for thymic epithelial neoplasms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis in patients operated in four high-volume Italian thoracic surgery centers, followed for a minimum period of 6 months. Immediate preoperative values of NLR, PLR, and SII were recorded. Patients were categorized for each factor based on cutoff values determined statistically by using the Youden index. Survival outcomes were analyzed using Kaplan\u2013Meier curves, log-rank tests, and multivariable Cox regression after propensity score matching (1:1) performed for each inflammatory index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 376 patients were enrolled. The mean values for NLR, PLR, and SII were 3.0 (3.2), 131.4 (84.1), and 754.6 (28.8), respectively. The calculated cutoff values were 2.9 for NLR, 123.8 for PLR, and 489.0 for SII. After propensity score matching, we obtained 212 cases for NLR, 256 for PLR, and 280 for SII. Multivariable Cox regression analysis revealed a significant association between tumor-related survival and NLR (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.030) and SII (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher NLR and SII cutoff values can be considered predictors of worse thymic epithelial tumors-related survival after surgery, suggesting their potential role in long-term risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19281-1","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:52:15Z","timestamp":1771955535000},"page":"5368-5376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory Indices Related to the Postoperative Prognosis of Thymic Epithelial Neoplasms: A Propensity Score Matching Evaluation"],"prefix":"10.1245","volume":"33","author":[{"given":"Federica","family":"Carlea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandro","family":"Patirelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Voulaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica Maria","family":"Giudici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Meacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfilippo","family":"Crucitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Ambrogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"19281_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","volume":"99","author":"M Scorsetti","year":"2016","unstructured":"Scorsetti M, Leo F, Trama A, et al. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332\u201350.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"3","key":"19281_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jtho.2019.10.018","volume":"15","author":"H Liu","year":"2020","unstructured":"Liu H, Gu Z, Qiu B, et al. A recurrence predictive model for Thymic tumors and its implication for postoperative management: a Chinese Alliance for research in Thymomas database study. J Thorac Oncol. 2020;15(3):448\u201356.","journal-title":"J Thorac Oncol."},{"issue":"5","key":"19281_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ejcts\/ezaa453","volume":"59","author":"W Fang","year":"2021","unstructured":"Fang W, Filosso PL, Roden AC, et al. Clinicopathological features and current treatment outcomes of neuroendocrine thymic tumours. Eur J Cardiothorac Surg. 2021;59(5):10.","journal-title":"Eur J Cardiothorac Surg."},{"key":"19281_CR4","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jtho.2021.06.014","volume":"16","author":"BY Yeap","year":"2021","unstructured":"Yeap BY, De Rienzo A, Gill RR, et al. Mesothelioma risk score: a new prognostic pretreatment, clinical molecular algorithm for malignant pleural mesothelioma. J Thorac Oncol. 2021;16:1925\u201335.","journal-title":"J Thorac Oncol."},{"issue":"13","key":"19281_CR5","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1158\/1078-0432.CCR-18-3661","volume":"25","author":"U De Giorgi","year":"2019","unstructured":"De Giorgi U, Procopio G, Giannarelli D, et al. Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with Nivolumab. Clin Cancer Res. 2019;25(13):3839\u201346.","journal-title":"Clin Cancer Res."},{"issue":"6","key":"19281_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/SLA.0000000000002018","volume":"266","author":"S Yamashita","year":"2017","unstructured":"Yamashita S, Sheth RA, Niekamp AS, et al. Comprehensive complication index predicts cancer-specific survival after resection of colorectal metastases independent of RAS mutational status. Ann Surg. 2017;266(6):1045\u201354.","journal-title":"Ann Surg."},{"issue":"31","key":"19281_CR7","doi-asserted-by":"publisher","first-page":"21861","DOI":"10.18632\/oncotarget.25076","volume":"9","author":"S Janik","year":"2018","unstructured":"Janik S, Raunegger T, Hacker P, et al. Prognostic and diagnostic impact of fibrinogen, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome. Oncotarget. 2018;9(31):21861\u201375.","journal-title":"Oncotarget."},{"issue":"1","key":"19281_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13019-018-0805-7","volume":"13","author":"P Muriana","year":"2018","unstructured":"Muriana P, Carretta A, Ciriaco P, Bandiera A, Negri G. Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma. J Cardiothorac Surg. 2018;13(1):119.","journal-title":"J Cardiothorac Surg."},{"issue":"7","key":"19281_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.21037\/jtd.2016.05.05","volume":"8","author":"ZY Yuan","year":"2016","unstructured":"Yuan ZY, Gao SG, Mu JW, et al. Prognostic value of preoperative neutrophil-lymphocyte ratio is superior to platelet-lymphocyte ratio for survival in patients who underwent complete resection of thymic carcinoma. J Thorac Dis. 2016;8(7):148.","journal-title":"J Thorac Dis."},{"key":"19281_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2021.06.024","volume":"159","author":"RD Seban","year":"2021","unstructured":"Seban RD, Assie JB, Giroux-Leprieur E, et al. Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET\/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy. Lung Cancer. 2021;159:45\u201355.","journal-title":"Lung Cancer."},{"key":"19281_CR11","volume-title":"WHO classification of tumors, pathology and genetics of tumors of the lung, pleura, thymus and heart","author":"WT Travis","year":"2004","unstructured":"Travis WT, Brambilla E, Muller-Hermelink HK, et al. WHO classification of tumors, pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: France. IARC Press; 2004."},{"key":"19281_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","volume":"9","author":"A Marx","year":"2014","unstructured":"Marx A, Str\u00f6bel P, Badve SS. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol. 2014;9:596\u2013611.","journal-title":"J Thorac Oncol."},{"issue":"11","key":"19281_CR13","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48(11):2485\u201392.","journal-title":"Cancer."},{"issue":"5","key":"19281_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","volume":"44","author":"K Koga","year":"1994","unstructured":"Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int. 1994;44(5):359\u201367.","journal-title":"Pathol Int."},{"issue":"9 Suppl 2","key":"19281_CR15","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","volume":"9","author":"FC Detterbeck","year":"2014","unstructured":"Detterbeck FC, Stratton K, Giroux D, et al. The IASLC\/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9(9 Suppl 2):S65-72.","journal-title":"J Thorac Oncol."},{"issue":"2","key":"19281_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3414\/ME14-04-0003","volume":"54","author":"G Hughes","year":"2015","unstructured":"Hughes G. Youden\u2019s index and the weight of evidence. Methods Inf Med. 2015;54(2):198\u20139.","journal-title":"Methods Inf Med."},{"issue":"3","key":"19281_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/cncr.10226","volume":"94","author":"M Okumura","year":"2002","unstructured":"Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002;94(3):624\u201332.","journal-title":"Cancer."},{"key":"19281_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"24","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;24:436\u201344.","journal-title":"Nature."},{"key":"19281_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.692142","volume":"11","author":"AER Kartikasari","year":"2021","unstructured":"Kartikasari AER, Huertas CS, Mitchell A, Plebanski M. Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis. Front Oncol. 2021;11:692142.","journal-title":"Front Oncol."},{"issue":"1","key":"19281_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.it.2015.11.008","volume":"37","author":"DR Powell","year":"2016","unstructured":"Powell DR, Huttenlocher A. Neutrophils in the tumor microenvironment. Trends Immunol. 2016;37(1):41\u201352.","journal-title":"Trends Immunol."},{"issue":"4","key":"19281_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ccr.2011.02.007","volume":"19","author":"DB Stairs","year":"2011","unstructured":"Stairs DB, Bayne LJ, Rhoades B, et al. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell. 2011;19(4):470\u201383.","journal-title":"Cancer Cell."},{"issue":"1","key":"19281_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-017-0707-7","volume":"16","author":"A Ocana","year":"2017","unstructured":"Ocana A, Nieto-Jimenez C, Pandiella A, Templeton AJ. Neutrophils in cancer: prognostic role and therapeutic strategies. Mol Cancer. 2017;16(1):137.","journal-title":"Mol Cancer."},{"issue":"3","key":"19281_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcancer.2013.02.005","volume":"23","author":"CA Dumitru","year":"2013","unstructured":"Dumitru CA, Lang S, Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin Cancer Biol. 2013;23(3):141\u20138.","journal-title":"Semin Cancer Biol."},{"issue":"10","key":"19281_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ctrv.2015.10.003","volume":"41","author":"TF Nishijima","year":"2015","unstructured":"Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):971\u20138.","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"19281_CR25","doi-asserted-by":"publisher","first-page":"11210","DOI":"10.1038\/s41598-020-66387-x","volume":"10","author":"H Wang","year":"2020","unstructured":"Wang H, Chen WM, Zhou YH, Shi JP, Huang YQ, Wang WJ. Combined PLT and NE to predict the prognosis of patients with locally advanced cervical cancer. Sci Rep. 2020;10(1):11210.","journal-title":"Sci Rep."},{"issue":"15","key":"19281_CR26","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.3390\/jcm12154912","volume":"12","author":"F Tacconi","year":"2023","unstructured":"Tacconi F, Mangiameli G, Voulaz E, et al. Blood-derived systemic inflammation markers and risk of nodal failure in stage IA non-small cell lung cancer: a multicentric study. J Clin Med. 2023;12(15):4912.","journal-title":"J Clin Med."},{"issue":"1","key":"19281_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1186\/s12885-021-08585-y","volume":"21","author":"YY Huang","year":"2021","unstructured":"Huang YY, Wu LL, Liu X, Liang SH, Ma GW. Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery. BMC Cancer. 2021;21(1):847.","journal-title":"BMC Cancer."},{"key":"19281_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155149","volume":"133","author":"L Wang","year":"2020","unstructured":"Wang L, Ruan M, Yan H, et al. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors. Cytokine. 2020;133:155149.","journal-title":"Cytokine."},{"issue":"1","key":"19281_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13019-018-0805-7","volume":"13","author":"P Muriana","year":"2018","unstructured":"Muriana P, Carretta A, Ciriaco P, Bandiera A, Negri G. Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma. J Cardiothorac Surg. 2018;13(1):119. https:\/\/doi.org\/10.1186\/s13019-018-0805-7.","journal-title":"J Cardiothorac Surg."},{"issue":"4","key":"19281_CR30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00595-017-1602-y","volume":"48","author":"M Yanagiya","year":"2018","unstructured":"Yanagiya M, Nitadori JI, Nagayama K, Anraku M, Sato M, Nakajima J. Prognostic significance of the preoperative neutrophil-to lymphocyte ratio for complete resection of thymoma. Surg Today. 2018;48(4):422\u201330.","journal-title":"Surg Today."},{"issue":"1","key":"19281_CR31","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1038\/s41598-019-54906-4","volume":"9","author":"C Veraar","year":"2019","unstructured":"Veraar C, Janik S, Thanner J, et al. Clinical prognostic scores for patients with thymic epithelial tumors. Sci Rep. 2019;9(1):18581.","journal-title":"Sci Rep."},{"issue":"13","key":"19281_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/1759-7714.14854","volume":"14","author":"Q Li","year":"2023","unstructured":"Li Q, Pu Y, Gong Z, et al. Preoperative systemic immune-inflammation index for predicting the prognosis of thymoma with radical resection. Thorac Cancer. 2023;14(13):1192\u2013200.","journal-title":"Thorac Cancer."},{"issue":"15","key":"19281_CR33","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1111\/1759-7714.14485","volume":"13","author":"T Sakane","year":"2022","unstructured":"Sakane T, Okuda K, Matsui T. Prognostic value of systemic inflammatory markers and the nutrition status in thymic epithelial tumors with complete resection. Thorac Cancer. 2022;13(15):2127\u201333.","journal-title":"Thorac Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19281-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19281-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19281-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:02:23Z","timestamp":1778911343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19281-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19281"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19281-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None declared.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}